SCHEMBL11034239

SCHEMBL11034239

O=C1CCC=C2Nc3ccccc3C=C12

nearest known ligand 0.34

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.33
MAPK13 O15264 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33
AHR P35869 1/20 0.30
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9693452 0.76 GAA (0.39) MAPTGAA
SCHEMBL7915886 0.75 GAA (0.35) MAPTGAANPC1MAPK13MAPK12
SCHEMBL5210927 0.70 GAA (0.36) MAPTGAA
SCHEMBL22893252 0.65 GAA (0.35) MAPTGAA
SCHEMBL7549500 0.63
SCHEMBL22893207 0.61 MAPT (0.47) MAPTGAAAHRPDK2
SCHEMBL11133453 0.61 BACE1 (0.41) MAPTGAANPC1
SCHEMBL6441771 0.61 NPC1 (0.52) MAPTGAANPC1MAPK13MAPK12
SCHEMBL18815020 0.59 CDC25A (0.38) MAPTGAANPC1MAPK13MAPK12
SCHEMBL15099958 0.59 CRBN (0.40) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-59091150-A None JP disclosed
US-10374168-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
US-20170125701-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-05-04 US disclosed
JP-S5991150-A DIHYDROACRIDONE DERIVATIVE AND PRODUCTION THEREOF TOYO SODA MFG CO LTD 1984-05-25 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170125701-A1 MATERIALS FOR ELECTRONIC DEVICES HCN2, EFNA1, EED MAPT 3649/4885GAA 2904/4885NPC1 3627/4885
US-10374168-B2 Materials for electronic devices HCN2, EFNA1, EED MAPT 3649/4885GAA 2904/4885NPC1 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.